ANNA WILCHER: Open Payments
NPI 1710665716 · BEAVERCREEK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,650 in 151 payments from 20 companies in 2025. Trend: 2023 $34 · 2024 $1,184 · 2025 $2,650
Food & beverage: $2,650
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $587 |
| Axsome Therapeutics, Inc. | 17 | $429 |
| Otsuka America Pharmaceutical, Inc. | 17 | $264 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $185 |
| Supernus Pharmaceuticals, Inc. | 9 | $175 |
| Neos Therapeutics, LP | 12 | $136 |
| Vanda Pharmaceuticals Inc. | 5 | $126 |
| Biogen, Inc. | 4 | $121 |
| Almatica Pharma LLC | 4 | $101 |
| Teva Pharmaceuticals USA, Inc. | 4 | $86 |
Products named: VRAYLAR, Auvelity, REXULTI, CAPLYTA, Qelbree, ZURZUVAE, Adzenys XR-ODT, LOREEV XR.
Industry payments across OH — which companies pay providers there.
